SCHEMBL20304513

SCHEMBL20304513

O=C(O)N(C(=O)O)c1cc2ccccc2c(Br)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
GLA P06280 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TRPM8 Q7Z2W7 1/20 0.43
RXFP1 Q9HBX9 2/20 0.40
GRM2 Q14416 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
GPR35 Q9HC97 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PDE10A Q9Y233 1/20 0.35
NR4A1 P22736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20296817 0.84 MEN1 (0.43) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL4154983 0.80 TRPM8 (0.41) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL20296577 0.78 TRPM8 (0.38) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL20296595 0.77 GRM2 (0.46) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL17559731 0.75 MEN1 (0.44) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL31165745 0.74 MEN1 (0.55) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL30170784 0.71 PAX8 (0.43) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL20315161 0.71 PAX8 (0.43) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL29517495 0.71 PAX8 (0.43) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL19616668 0.70 KMT2A (0.46) MEN1KMT2AKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558955-A2 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER Amgen Inc. (US) 2019-10-30 EP disclosed
WO-2018119183-A2 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. (US) 2018-06-28 WO disclosed